Product Images Alvesco

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Alvesco NDC 59368-100 by Sixarp, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural Formula - image 01

Structural Formula - image 01

Figure 1 - image 02

Figure 1 - image 02

Figure 2 - image 03

Figure 2 - image 03

Figure 3 - image 04

Figure 3 - image 04

This is a table showing the mean change in FEV1 (forced expiratory volume in one second) in liters for different time points and treatment groups. The data includes measurements before the morning dose of medication over several weeks. Two treatment groups are mentioned: one receiving a placebo and the other receiving Avesco at two different daily doses (320 μg/day and 640 μg/day). The table suggests a comparison of the effects of these treatments on lung function based on FEV1 measurements.*

Figure A - image 05

Figure A - image 05

Figure B - image 06

Figure B - image 06

Figure C - image 07

Figure C - image 07

Figure D - image 08

Figure D - image 08

Figure E - image 09

Figure E - image 09

Figure F - image 10

Figure F - image 10

Figure G - image 11

Figure G - image 11

Figure H - image 12

Figure H - image 12

Figure I - image 13

Figure I - image 13

Principal Display Panel - 80 mcg Carton - image 14

Principal Display Panel - 80 mcg Carton - image 14

This is a description of ALVESCO® Inhalation Aerosol, a medication containing ciclesonide in a propellant solution. Each 6.1g canister delivers 80 mcg/actuation of ciclesonide. It is essential to read the package insert for dosage information and follow the patient's instructions. The canister should be stored between 15-30°C (50-86°F) and never be punctured or exposed to heat or flames. It is manufactured by Covis Pharma in Switzerland and intended for oral inhalation only.*

Principal Display Panel - 160 mcg Carton - image 15

Principal Display Panel - 160 mcg Carton - image 15

This is a description for ALVESCO® Inhalation Aerosol, a medication containing ciclesonide in propellant HFA-134a and ethanol. Each 6.1g canister delivers 200mcg from the valve and 160mcg of ciclesonide from the actuator. The product should be stored at room temperature, protected from heat and open flame. It is essential to follow the dosage instructions provided in the package insert and to keep the canister out of reach of children. The medication is designed for oral inhalation with the ALVESCO® Inhalation Aerosol actuator.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.